Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …

Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …

In a prior multicenter randomized controlled trial, we found that a 12-week course of
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

The aim of our study was to assess the efficacy of extracorporeal photopheresis (ECP) in
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …

The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …

Extracorporeal photopheresis (ECP) has been widely used as a second line therapy for
treatment of cGVHD with recognized efficacy as a steroid sparing intervention (2, 3). It is a …

Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …